 In 1992, he joined Merck & Co.'s public affairs division as general counsel.Frazier was named senior general counsel in 1999.As general counsel, he was credited with overseeing the company's defense against claims that the anti-inflammatory drug Vioxx had caused heart attacks and strokes.